# Famotidine Compared With Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/Erosion

> **NCT00843063** · PHASE4 · COMPLETED · sponsor: **Ruttonjee Hospital** · enrollment: 161 (actual)

## Conditions studied

- Peptic Ulcer/Erosions

## Interventions

- **DRUG:** pantoprazole vs famotidine

## Key facts

- **NCT ID:** NCT00843063
- **Lead sponsor:** Ruttonjee Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2009-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00843063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00843063, "Famotidine Compared With Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/Erosion". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00843063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*